squamous cell carcinoma
This SRC-3 overexpression frequency was similar to the overexpression frequency observed for squamous cell carcinoma and adenocarcinoma (82.1% vs 90%) and for metastasis and non-metastasis patients (84.6% vs 85.7%).
This <span class="gene" id="20852035-6-5-10">SRC-3</span> overexpression frequency was similar to the overexpression frequency observed for <span class="disease" id="20852035-6-93-116">squamous cell carcinoma</span> and adenocarcinoma (82.1% vs 90%) and for metastasis and non-metastasis patients (84.6% vs 85.7%).